The treatment concludes with a Lipo+ intramuscular injection, a targeted blend of B6, methionine, inositol, and cholinekey nutrients that aid in fat breakdown and liver support
H., Kim, D., Jung, Y
Monitor for: Gastrointestinal symptoms: Nausea or vomiting (occurring in approximately 1520% of patients at therapeutic doses per FDA labeling) Abdominal pain or cramping Diarrhea or constipation Loss of appetite or early satiety Bloating or abdominal distension Hypoglycemia indicators (particularly if you take other diabetes medications): Trembling, shakiness, or sweating Rapid heartbeat or palpitations Dizziness, lightheadedness, or confusion Hunger or irritability Headache or blurred vision Injection site reactions: Bruising, swelling, or hematoma formation Persistent pain or tenderness Redness or warmth suggesting inflammation Hardness or nodule formation under the skin Semaglutide's mechanism involves glucose-dependent insulin secretion, meaning hypoglycemia risk is generally low when used as monotherapy
approved for type 2 diabetes, with some formulations phased out over time
If you are worried about how taking Ozempic will affect your appearance or experiencing facial changes, you may consider more intensive forms of treatment
